AUS
NZ
UK
CA
USA
IND
Headlines
- IBM's R&D Shutdown and Job Relocation
- Mixed Growth Metrics and Market Challenges
- Evaluating IBM Through Peter Lynch's Lens
International Business Machines (NYSE:IBM) recently announced the closure of its R&D division in China, leading to over 1,000 job losses. Some roles will shift to Bangalore, India, which houses a large segment of IBM’s operations. Despite a 20% increase in share price this year and a 58% rise over the last five years, IBM’s performance lags behind tech leaders like Microsoft(NASDAQ:MSFT), Amazon (NASDAQ:AMZN), and Alphabet(NASDAQ:GOOG), who have capitalized on the AI boom.
IBM's efforts to revitalize its business include spinning off its consulting division into Kyndryl, now valued over $5 billion. Cost-cutting measures have also been a focus, with IBM reducing its workforce by 3,900 employees in 2023 and recently halting its Chinese R&D operations. These steps have improved IBM’s operating margin, which increased from 2.9% in 2022 to 12.1% in 2023. However, this has not significantly boosted sales, with a modest 2.2% revenue growth in 2023, contrasting sharply with competitors like Microsoft and Google.
In the second quarter of this year, IBM's revenue rose by only 2% to $15.8 billion, while its gross profit margin grew to 56.8%. Although the software division saw a 7.1% revenue increase, consulting revenues declined slightly, and infrastructure revenue showed minimal growth. These figures indicate limited meaningful growth for the company.
Examining IBM’s market presence, it falls short in crucial industries. Despite years of investment in its Watson product, IBM hasn’t captured substantial market share, especially in AI, where competitors like Nvidia, Microsoft, and Google dominate. Similarly, IBM lags in cloud computing, holding just a 2% market share compared to leaders like AWS and Azure.
Applying Peter Lynch's Growth at a Reasonable Price (GARP) strategy reveals mixed findings for IBM. The company's trailing P/E ratio of 21 exceeds Lynch's preferred threshold of 15. Although IBM's debt-to-equity ratio and PEG ratio align with Lynch's criteria, the high forward P/E ratio of 21.6 suggests it may be considered overvalued based on Lynch's standards.
